Risk of Ocular Adverse Events With Taxane-Based Chemotherapy
IMPORTANCE: Taxane-based chemotherapy agents, such as docetaxel and paclitaxel, are used for treating a wide range of cancers. Although much has been published on adverse events related to taxanes, data on ocular outcomes with these very important drugs are scant. OBJECTIVE: To quantify the risk of...
Gespeichert in:
Veröffentlicht in: | Archives of ophthalmology (1960) 2022-09, Vol.140 (9), p.880-884 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!